Chicago-based GE HealthCare announced it closed its acquisition of AI and imaging solutions company MIM Software, expanding its digital imaging offerings.
Cleveland-based MIM Software provides remote software solutions for oncology, nuclear medicine, cardiac imaging and neuroimaging.
The company touts its products as reducing time spent on manual tasks, allowing clinicians to focus on providing cancer care to patients. MIM, or Medical Image Merge, launched in 2003 as an imaging product for manipulating and reading DICOM images.
MIM Software offerings will be sold under the GE HealthCare brand, including MIM SurePlan, MIM Symphony and MIM Maestro.
Financial details regarding the deal were not disclosed; however, GE HealthCare said in a statement that the transaction was completed with cash on hand.
“We are thrilled to welcome MIM Software, known for driving innovation in multimodal image analytics and workflow, to our global GE HealthCare team. These new capabilities align with our precision care strategy to personalize care, enhance hospital efficiency and clinician effectiveness, and appeal to new and existing GE HealthCare and MIM Software users who see this as an opportunity to better serve patients and help improve outcomes,” relayed Peter Arduini, president and CEO of GE HealthCare, in a statement.
THE LARGER TREND
MIM Software first received FDA clearance for its mobile MIM radiology app in 2011. The app allows remote viewing of high-resolution X-ray and ultrasound images downloaded from a cloud-based service. In the app’s latest version, providers can view dose-volume histograms, isodose curves, and images for treatment plans.
In December, the imaging company announced it secured FDA clearance for Contour ProtegeAI+, an automatic auto-contouring tool that reduces manual contouring processes and allows more time to create cancer treatment plans.
MIM is GE HealthCare’s third acquisition as an independent company. The company acquired CT interventional guidance company IMACTIS in 2023 and AI ultrasound producer Caption Health.
GE HealthCare has secured several FDA clearances since it was spun out of GE in early 2023.
The same year, the company received FDA clearance for Precision DL, aimed to improve screening time, image quality and small lesion detection, and clearance for a device the size of a smartphone called Portrait Mobile for monitoring patient respiration rates remotely.
In February, GE HealthCare scored FDA clearance for Novii+, a maternal and fetal monitoring platform for high-risk pregnancy.
The company recently announced its Brazilian-based partner Ionic Health secured FDA clearance for its remote imaging software, which provides diagnostic imaging centers with real-time scanning, remote guidance and operational support, and the ability to view/review images remotely.
